Trends in hypertension prevalence, awareness, treatment, and control in South Korea, 1998-2021: a nationally representative serial study.
Journal
Scientific reports
ISSN: 2045-2322
Titre abrégé: Sci Rep
Pays: England
ID NLM: 101563288
Informations de publication
Date de publication:
08 Dec 2023
08 Dec 2023
Historique:
received:
20
06
2023
accepted:
04
12
2023
medline:
9
12
2023
pubmed:
9
12
2023
entrez:
8
12
2023
Statut:
epublish
Résumé
The impact of the pandemic on hypertension management is unknown, particularly regarding changes in demographic risk factors. We conducted a comprehensive study between 1998 and 2021 on the long-term trends in hypertension prevalence in South Korea, including a comparison of the pre-pandemic and pandemic eras. Data from 1998 to 2021 of 108,687 Korean adults were obtained through a nationwide, large-scale, and serial study. We conducted a weighted complex sampling analysis on the estimates of national prevalence and compared the slope of hypertension prevalence before and during the pandemic to determine the trend dynamics. We included 108,687 participants over 24 years, 1998-2021. While the prevalence of patients with hypertension consistently increased before the pandemic from 25.51% [95% CI: 24.27-26.75] in 1998-2005 to 27.81% [95% CI: 26.97-28.66] in 2016-2019, the increasing slope in hypertension prevalence slowed during the pandemic period (28.07% [95% CI: 26.16-29.98] for 2021; β
Identifiants
pubmed: 38066091
doi: 10.1038/s41598-023-49055-8
pii: 10.1038/s41598-023-49055-8
pmc: PMC10709599
doi:
Types de publication
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Pagination
21724Subventions
Organisme : National Research Foundation of Korea
ID : RS-2023-00248157
Organisme : Ministry of Food and Drug Safety
ID : 21153MFDS601
Organisme : Korea Health Industry Development Institute
ID : HE23C002800
Pays : Republic of Korea
Informations de copyright
© 2023. The Author(s).
Références
Int J Epidemiol. 2014 Feb;43(1):69-77
pubmed: 24585853
Lancet. 2021 Sep 11;398(10304):957-980
pubmed: 34450083
Sci Rep. 2023 Feb 13;13(1):2548
pubmed: 36781890
Online J Public Health Inform. 2022 Aug 11;14(1):e3
pubmed: 36120163
Korean Circ J. 2022 May;52(5):382-392
pubmed: 35257521
Gut. 2021 Oct;70(10):2013-2015
pubmed: 33303566
BMC Public Health. 2022 Jul 22;22(1):1401
pubmed: 35864469
Clin Hypertens. 2022 Jan 3;28(1):1
pubmed: 34980274
J Clin Med. 2021 Jan 05;10(1):
pubmed: 33466237
Lancet Digit Health. 2022 Jul;4(7):e480-e481
pubmed: 35750399
BMJ. 2023 Jan 11;380:e071952
pubmed: 36631148
Syst Rev. 2022 Nov 17;11(1):242
pubmed: 36397129
Int J Environ Res Public Health. 2023 Jan 05;20(2):
pubmed: 36673736
JMIR Med Inform. 2020 Aug 25;8(8):e20992
pubmed: 32784189
World J Pediatr. 2023 Apr;19(4):366-377
pubmed: 36645642
J Med Internet Res. 2020 Jun 9;22(6):e19264
pubmed: 32463377
Sci Rep. 2019 Jul 29;9(1):10970
pubmed: 31358791
Soc Sci Humanit Open. 2021;4(1):100150
pubmed: 33880443
Clin Hypertens. 2023 Oct 12;29(1):28
pubmed: 37821979
PLoS One. 2021 Feb 11;16(2):e0246824
pubmed: 33571297
J Allergy Clin Immunol Pract. 2019 Nov - Dec;7(8):2912-2915.e2
pubmed: 31129074
J Endocr Soc. 2020 Jul 21;4(9):bvaa102
pubmed: 32885126
Allergy. 2023 Jun;78(6):1665-1670
pubmed: 36440490
Korean Circ J. 2020 Dec;50(12):1077-1091
pubmed: 32975054
Environ Pollut. 2019 Nov;254(Pt A):112934
pubmed: 31376601
World J Pediatr. 2023 Nov;19(11):1071-1081
pubmed: 36977821
Int J Environ Res Public Health. 2022 Oct 18;19(20):
pubmed: 36294058
J Med Virol. 2023 Feb;95(2):e28456
pubmed: 36602052
Lancet Psychiatry. 2021 Apr;8(4):271-272
pubmed: 33617761
PLoS One. 2021 Sep 29;16(9):e0258015
pubmed: 34587198
Diabetes Res Clin Pract. 2020 Nov;169:108463
pubmed: 32971150